CD68 and Alzheimer disease: A co-localization of plaques, microglia, and CD68 well revealed that hDPSCs-treated mice appeared to have a slight decrease in the integrated density of the CD68-marked area surrounding the plaques relative to AD+PBS mice (Figure 7A, B).